Document is current
Any future updates will be listed below
-
Authors
Hiraiwa, Hiroaki https://orcid.org/0000-0002-1606-7037
Nagai, Shin
Ito, Ryota
Kondo, Kiyota
Kazama, Shingo
Kondo, Toru https://orcid.org/0000-0001-6853-7574
Adachi, Shiro https://orcid.org/0000-0001-8924-1916
Furusawa, Kenji
Tanaka, Akihito https://orcid.org/0000-0003-2260-1942
Morimoto, Ryota https://orcid.org/0000-0003-0931-3188
Okumura, Takahiro https://orcid.org/0000-0001-5076-2052
Murohara, Toyoaki https://orcid.org/0000-0003-2723-6243
-
Funding
Funding for this research was provided by:
Konica Minolta, Inc.
Konica Minolta Science and Technology Foundation
Kowa Life Science Foundation
Nagoya University
- License Information
-
More Information
Article History
Received: 3 July 2024
Accepted: 8 January 2025
First Online: 25 January 2025
Declarations
:
: H.H. has received research grants from Konica Minolta, Inc., Konica Minolta Science and Technology Foundation, and Kowa Life Science Foundation. T.K. has received lecture fees from Abbott Medical Japan LLC., Ono Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Novartis Pharma K.K., AstraZeneca K.K., Bristol-Myers Squibb Co., and Abiomed Japan K.K. T.O. has received research grants from Ono Pharmaceutical Co. Ltd., Amgen Astellas BioPharma K.K., Pfizer Japan Inc., Alnylam Pharmaceuticals, Inc., and Alexion Pharmaceuticals, Inc. T.O. has received lecture fees from Ono Pharmaceutical Co. Ltd., Otsuka Pharma Ltd., Novartis Pharma K.K., and AstraZeneca K.K. T.M. has received an unrestricted research grant from the Department of Cardiology, Nagoya University Graduate School of Medicine, from Astellas Pharma Inc., Daiichi-Sankyo Co. Ltd., Dainippon Sumitomo Pharma Co. Ltd., Kowa Co. Ltd., MSD K.K., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co. Ltd., Novartis Pharma K.K., Otsuka Pharma Ltd., Pfizer Japan Inc., Sanofi-Aventis K.K., Takeda Pharmaceutical Co. Ltd., and Teijin Pharma Ltd. The other authors declare that they have no conflicts of interest associated with this manuscript.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Nagoya University Graduate School of Medicine (Date: 30 June 2023/No. 2023-0103).
: Written informed consent was obtained from all individual participants included in the study.
: Written informed consent was obtained from all individual participants included in the study.
